Myriad Genetics
MYGN
MYGN
220 hedge funds and large institutions have $2.72B invested in Myriad Genetics in 2017 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 76 increasing their positions, 86 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
12% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 86
35% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 37
50% less call options, than puts
Call options by funds: $9.46M | Put options by funds: $19M
Holders
220
Holding in Top 10
6
Calls
$9.46M
Puts
$19M
Top Buyers
| 1 | +$16.9M | |
| 2 | +$15.3M | |
| 3 | +$15.1M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$12.4M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$12.2M |
Top Sellers
| 1 | -$66.6M | |
| 2 | -$66.1M | |
| 3 | -$46.8M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$36.2M |
| 5 |
Millennium Management
New York
|
-$30.8M |